264 related articles for article (PubMed ID: 21289303)
1. Local inactivation of sphingosine 1-phosphate in lymph nodes induces lymphopenia.
Sensken SC; Nagarajan M; Bode C; Gräler MH
J Immunol; 2011 Mar; 186(6):3432-40. PubMed ID: 21289303
[TBL] [Abstract][Full Text] [Related]
2. Redistribution of sphingosine 1-phosphate by sphingosine kinase 2 contributes to lymphopenia.
Sensken SC; Bode C; Nagarajan M; Peest U; Pabst O; Gräler MH
J Immunol; 2010 Apr; 184(8):4133-42. PubMed ID: 20220090
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients.
Schwab SR; Pereira JP; Matloubian M; Xu Y; Huang Y; Cyster JG
Science; 2005 Sep; 309(5741):1735-9. PubMed ID: 16151014
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
Maeda Y; Seki N; Sato N; Sugahara K; Chiba K
Int Immunol; 2010 Jun; 22(6):515-25. PubMed ID: 20497959
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses.
Wei SH; Rosen H; Matheu MP; Sanna MG; Wang SK; Jo E; Wong CH; Parker I; Cahalan MD
Nat Immunol; 2005 Dec; 6(12):1228-35. PubMed ID: 16273098
[TBL] [Abstract][Full Text] [Related]
6. Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720.
Morris MA; Gibb DR; Picard F; Brinkmann V; Straume M; Ley K
Eur J Immunol; 2005 Dec; 35(12):3570-80. PubMed ID: 16285007
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine 1-phosphate and its type 1 G protein-coupled receptor: trophic support and functional regulation of T lymphocytes.
Goetzl EJ; Gräler MH
J Leukoc Biol; 2004 Jul; 76(1):30-5. PubMed ID: 14982946
[TBL] [Abstract][Full Text] [Related]
8. The role of the lysophospholipid sphingosine 1-phosphate in immune cell biology.
von Wenckstern H; Zimmermann K; Kleuser B
Arch Immunol Ther Exp (Warsz); 2006; 54(4):239-51. PubMed ID: 16830220
[TBL] [Abstract][Full Text] [Related]
9. Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P.
Matsuyuki H; Maeda Y; Yano K; Sugahara K; Chiba K; Kohno T; Igarashi Y
Cell Mol Immunol; 2006 Dec; 3(6):429-37. PubMed ID: 17257496
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1.
Matloubian M; Lo CG; Cinamon G; Lesneski MJ; Xu Y; Brinkmann V; Allende ML; Proia RL; Cyster JG
Nature; 2004 Jan; 427(6972):355-60. PubMed ID: 14737169
[TBL] [Abstract][Full Text] [Related]
11. Finding a way out: lymphocyte egress from lymphoid organs.
Schwab SR; Cyster JG
Nat Immunol; 2007 Dec; 8(12):1295-301. PubMed ID: 18026082
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine-1-phosphate modulates vascular permeability and cell recruitment in acute inflammation in vivo.
Roviezzo F; Brancaleone V; De Gruttola L; Vellecco V; Bucci M; D'Agostino B; Cooper D; Sorrentino R; Perretti M; Cirino G
J Pharmacol Exp Ther; 2011 Jun; 337(3):830-7. PubMed ID: 21421740
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of fingolimod (FTY720) in lymphoid tissues contributes to prolonged efficacy.
Sensken SC; Bode C; Gräler MH
J Pharmacol Exp Ther; 2009 Mar; 328(3):963-9. PubMed ID: 19074680
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of collagen-induced arthritis by a novel S1P1 antagonist with immunomodulatory activities.
Fujii Y; Hirayama T; Ohtake H; Ono N; Inoue T; Sakurai T; Takayama T; Matsumoto K; Tsukahara N; Hidano S; Harima N; Nakazawa K; Igarashi Y; Goitsuka R
J Immunol; 2012 Jan; 188(1):206-15. PubMed ID: 22131329
[TBL] [Abstract][Full Text] [Related]
15. S1P-lyase independent clearance of extracellular sphingosine 1-phosphate after dephosphorylation and cellular uptake.
Peest U; Sensken SC; Andréani P; Hänel P; Van Veldhoven PP; Gräler MH
J Cell Biochem; 2008 Jun; 104(3):756-72. PubMed ID: 18172856
[TBL] [Abstract][Full Text] [Related]
16. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.
Mandala S; Hajdu R; Bergstrom J; Quackenbush E; Xie J; Milligan J; Thornton R; Shei GJ; Card D; Keohane C; Rosenbach M; Hale J; Lynch CL; Rupprecht K; Parsons W; Rosen H
Science; 2002 Apr; 296(5566):346-9. PubMed ID: 11923495
[TBL] [Abstract][Full Text] [Related]
17. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs.
Hofmann M; Brinkmann V; Zerwes HG
Int Immunopharmacol; 2006 Dec; 6(13-14):1902-10. PubMed ID: 17161343
[TBL] [Abstract][Full Text] [Related]
18. Immune regulation by sphingosine 1-phosphate and its receptors.
Bode C; Gräler MH
Arch Immunol Ther Exp (Warsz); 2012 Feb; 60(1):3-12. PubMed ID: 22159476
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine-1-phosphate receptor type-1 agonism impairs blood dendritic cell chemotaxis and skin dendritic cell migration to lymph nodes under inflammatory conditions.
Gollmann G; Neuwirt H; Tripp CH; Mueller H; Konwalinka G; Heufler C; Romani N; Tiefenthaler M
Int Immunol; 2008 Jul; 20(7):911-23. PubMed ID: 18495625
[TBL] [Abstract][Full Text] [Related]
20. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
